# Oluwaseun Anyiam

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/oluwaseun-anyiam/

## Facts

| Field | Value |
| --- | --- |
| Citations | 261 |
| Field | Diabetes Treatment and Management |
| h-index | 6 |
| i10-index | 6 |
| Last Known Institution | University of Nottingham |
| OpenAlex ID | https://openalex.org/A5059068952 |
| ORCID iD | 0000-0003-2425-2299 |
| Works | 27 |

## Researcher papers

- [Combined GLP-1, Oxyntomodulin, and Peptide YY Improves Body Weight and Glycemia in Obesity and Prediabetes/Type 2 Diabetes: A Randomized, Single-Blinded, Placebo-Controlled Study](https://scholariq.org/papers/combined-glp-1-oxyntomodulin-and-peptide-yy-improves-body-weight-and-glycemia-in/)
- [Metabolic effects of very-low calorie diet, Semaglutide, or combination of the two, in individuals with type 2 diabetes mellitus](https://scholariq.org/papers/metabolic-effects-of-very-low-calorie-diet-semaglutide-or-combination-of-the-two/)
- [Cracking the combination: Gut hormones for the treatment of obesity and diabetes](https://scholariq.org/papers/cracking-the-combination-gut-hormones-for-the-treatment-of-obesity-and-diabetes/)
- [How do glucagon‐like Peptide‐1 receptor agonists affect measures of muscle mass in individuals with, and without, type 2 diabetes: A systematic review and meta‐analysis](https://scholariq.org/papers/how-do-glucagon-like-peptide-1-receptor-agonists-affect-measures-of-muscle-mass/)
- [A Systematic Review and Meta-Analysis of the Effect of Caloric Restriction on Skeletal Muscle Mass in Individuals with, and without, Type 2 Diabetes](https://scholariq.org/papers/a-systematic-review-and-meta-analysis-of-the-effect-of-caloric-restriction-on/)
- [The latest evidence and guidance in lifestyle and surgical interventions to achieve weight loss in people with overweight or obesity](https://scholariq.org/papers/the-latest-evidence-and-guidance-in-lifestyle-and-surgical-interventions-to/)
- [Type 2 Diabetes](https://scholariq.org/papers/type-2-diabetes-2/)
- [Weight loss with GLP-1 medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans](https://scholariq.org/papers/weight-loss-with-glp-1-medicines-does-not-result-in-a-disproportionate-loss-of/)
- [Subclinical hypothyroidism or central hypothyroidism—The danger of thyroid function misinterpretation](https://scholariq.org/papers/subclinical-hypothyroidism-or-central-hypothyroidism-the-danger-of-thyroid/)
- [A Complicated Pregnancy in an Adult with HNF4A p.R63W-Associated Fanconi Syndrome](https://scholariq.org/papers/a-complicated-pregnancy-in-an-adult-with-hnf4a-p-r63w-associated-fanconi/)

## Researcher topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Bariatric Surgery and Outcomes](https://scholariq.org/topics/bariatric-surgery-and-outcomes/)
- [Metabolism, Diabetes, and Cancer](https://scholariq.org/topics/metabolism-diabetes-and-cancer/)
- [Diet and metabolism studies](https://scholariq.org/topics/diet-and-metabolism-studies/)
- [Regulation of Appetite and Obesity](https://scholariq.org/topics/regulation-of-appetite-and-obesity/)

## Researcher university

- [University of Nottingham](https://scholariq.org/institutions/university-of-nottingham/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.